Location · Greenville, SC
Clinical trials in Greenville, SC
78 recruiting studies have a site in Greenville, and 11 of them accept healthy volunteers.
78 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Allogene Therapeutics
- Location
- Greenville, SC + 15 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Greenville, SC + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
AbbVie
- Location
- Greenville, SC + 10 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
OPKO Health, Inc.
- Location
- Greenville, SC
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Pfizer
- Location
- Greenville, SC + 26 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Greenville, SC + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Greenville, SC + 39 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
GORE® ENFORM Biomaterial Product Study
W.L.Gore & Associates
- Location
- Greenville, SC + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Axsome Therapeutics, Inc.
- Location
- Greenville, SC + 35 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Greenville, SC + 37 other US sites
- Eligibility basics
- Ages 40–75
- Recruiting
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study
Recross Cardio, Inc.
- Location
- Greenville, SC + 4 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Greenville, SC + 43 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Integrity Implant System Post Market Clinical Follow-Up Study
Anika Therapeutics, Inc.
- Location
- Greenville, SC + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Greenville, SC + 77 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney…
Alexion Pharmaceuticals, Inc.
- Location
- Greenville, SC + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Baxis Pharmaceuticals, Inc.
- Location
- Greenville, SC + 20 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Greenville, SC + 42 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 4
CraniSeal Post Approval Study
Pramand LLC
- Location
- Greenville, SC + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
VenoStent
- Location
- Greenville, SC + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Greenville, SC + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 4
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
Angiodynamics, Inc.
- Location
- Greenville, SC + 8 other US sites
- Eligibility basics
- Any age listed
- Recruiting
Long-Term Stability of the Glide Control Strategy
Infinite Biomedical Technologies
- Location
- Greenville, SC + 9 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Concept Medical Inc.
- Location
- Greenville, SC + 23 other US sites
- Eligibility basics
- Ages 18–110
- RecruitingHealthy volunteers
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
NRG Oncology
- Location
- Greenville, SC + 29 other US sites
- Eligibility basics
- Ages 18+